Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first …
ER Haspinger, F Agustoni, V Torri, F Gelsomino… - Critical reviews in …, 2015 - Elsevier
Three EGFR tyrosine kinase inhibitors have been compared to standard chemotherapy as
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first …
ER Haspinger, F Agustoni, V Torri… - Critical Reviews in …, 2014 - europepmc.org
Three EGFR tyrosine kinase inhibitors have been compared to standard chemotherapy as
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …
[PDF][PDF] Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy …
ER Haspinger, F Agustoni, V Torri… - Critical Reviews in …, 2015 - researchgate.net
Abstract ThreeEGFRtyrosinekinaseinhibitorshavebe…-
fronttreatmentinpatientswithadvancedEGFR-positive NSCLC. We performed a systematic …
fronttreatmentinpatientswithadvancedEGFR-positive NSCLC. We performed a systematic …
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first …
ER Haspinger, F Agustoni, V Torri, F Gelsomino… - Critical Reviews in …, 2015 - infona.pl
Three EGFR tyrosine kinase inhibitors have been compared to standard chemotherapy as
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first …
ER Haspinger, F Agustoni, V Torri… - Critical reviews in …, 2015 - pubmed.ncbi.nlm.nih.gov
Three EGFR tyrosine kinase inhibitors have been compared to standard chemotherapy as
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …
up-front treatment in patients with advanced EGFR-positive NSCLC. We performed a …